Prostanoids and inflammatory pain.
暂无分享,去创建一个
[1] H. Schaible,et al. Prostaglandins and cycloxygenases in the spinal cord , 2001, Progress in Neurobiology.
[2] M. Vasko,et al. Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons , 1994, Brain Research.
[3] K. Omote,et al. The Effects of Peripheral Administration of a Novel Selective Antagonist for Prostaglandin E Receptor Subtype EP1, ONO-8711, in a Rat Model of Postoperative Pain , 2001, Anesthesia and analgesia.
[4] S. Narumiya,et al. In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs , 1995, British journal of pharmacology.
[5] O. Yuge,,et al. Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. , 2007, European journal of pharmacology.
[6] Gerd Geisslinger,et al. Cyclooxygenase‐independent actions of cyclooxygenase inhibitors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] Tetsuya Abe,et al. Membrane-associated prostaglandin E synthase-1 is required for neuropathic pain , 2004, Neuroreport.
[8] M. Tominaga,et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins , 2005, Molecular pain.
[9] S. Narumiya,et al. Prostaglandin D2 as a mediator of allergic asthma. , 2000, Science.
[10] P. Isakson,et al. Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2. , 1995, Journal of immunology.
[11] K. Scholich,et al. Is mPGES-1 a promising target for pain therapy? , 2006, Trends in pharmacological sciences.
[12] Y. Urade,et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] O. Hayaishi,et al. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice. , 1996, The Journal of pharmacology and experimental therapeutics.
[14] Steve Rowland,et al. Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain. , 2010, Bioorganic & medicinal chemistry letters.
[15] J. de Belleroche,et al. Carrageenan‐induced hyperalgesia is associated with increased cyclo‐oxygenase‐2 expression in spinal cord , 1997, Neuroreport.
[16] C. Woolf,et al. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. , 2009, The journal of pain : official journal of the American Pain Society.
[17] S. Narumiya,et al. Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice. , 2000, Cancer letters.
[18] C. Maihöfner,et al. Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord , 2000, Neuroscience.
[19] N. Méthot,et al. MF63 [2-(6-Chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a Selective Microsomal Prostaglandin E Synthase-1 Inhibitor, Relieves Pyresis and Pain in Preclinical Models of Inflammation , 2008, Journal of Pharmacology and Experimental Therapeutics.
[20] S. Heller,et al. Protease-Activated Receptors: Mechanisms by Which Proteases Sensitize TRPV Channels to Induce Neurogenic Inflammation and Pain -- TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades , 2006 .
[21] S. Yoshikawa,et al. Functional role of prostacyclin receptor in rat dorsal root ganglion neurons , 2005, Neuroscience Letters.
[22] F. Cunha,et al. The role of NaV1.8 sodium channel in the maintenance of chronic inflammatory hypernociception , 2005, Neuroscience Letters.
[23] P. Isakson,et al. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. , 1998, The Journal of pharmacology and experimental therapeutics.
[24] Adam Sapirstein,et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity , 2001, Nature.
[25] H. Rang,et al. Effect of bradykinin and prostaglandins on the release of calcitonin gene‐related peptide‐like immunoreactivity from the rat spinal cord in vitro , 1993, British journal of pharmacology.
[26] Y. Murata,et al. CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties , 2007, Journal of Pharmacology and Experimental Therapeutics.
[27] J. Francischi,et al. Selective inhibitors of cyclo‐oxygenase‐2 (COX‐2) induce hypoalgesia in a rat paw model of inflammation , 2002, British journal of pharmacology.
[28] R. Breyer,et al. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. , 2004, Pharmacology & therapeutics.
[29] L. Audoly,et al. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. , 2002, The Journal of clinical investigation.
[30] J. Eisenach,et al. Cyclooxygenase-1 in the Spinal Cord Is Altered after Peripheral Nerve Injury , 2003, Anesthesiology.
[31] J. Lapointe,et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[32] Makoto Murakami,et al. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. , 2005, Journal of biochemistry and molecular biology.
[33] I. Chessell,et al. The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain. , 2007, Bioorganic & medicinal chemistry letters.
[34] M. Koyama,et al. Expression of prostaglandin EP2 receptor mRNA in the rat spinal cord. , 1997, Life sciences.
[35] R. Langenbach,et al. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. , 1999, Biochemical pharmacology.
[36] T. Kumazawa,et al. EP receptor subtypes implicated in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat. , 1996, Journal of neurophysiology.
[37] A. Kawabata. Prostaglandin E2 and pain--an update. , 2011, Biological & pharmaceutical bulletin.
[38] G. FitzGerald,et al. Microsomal prostaglandin E synthase‐1 inhibition in cardiovascular inflammatory disease , 2008, Journal of internal medicine.
[39] C. Asante,et al. The Cell and Molecular Basis of Mechanical, Cold, and Inflammatory Pain , 2008, Science.
[40] C. Saper,et al. COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. , 2009, The Journal of clinical investigation.
[41] S. Narumiya,et al. Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice , 2009, European journal of pain.
[42] S. Mutoh,et al. Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice. , 2003, Biochemical pharmacology.
[43] S. Giblett,et al. Prostanoids synthesized by cyclo‐oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability , 1997, British journal of pharmacology.
[44] G. FitzGerald,et al. Genetic and pharmacological analysis of prostanoid receptor function. , 2001, The Journal of clinical investigation.
[45] M. Vasko,et al. Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[46] T. Yaksh,et al. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] J. Levine,et al. Role of a Ca2+-dependent slow afterhyperpolarization in prostaglandin E2-induced sensitization of cultured rat sensory neurons , 1996, Neuroscience Letters.
[48] M. Nishizawa,et al. Central nociceptive role of prostacyclin (IP) receptor induced by peripheral inflammation , 2002, Neuroreport.
[49] T. Grosser,et al. PROSTANOIDS IN HEALTH AND DISEASE , 1979 .
[50] H Perrier,et al. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. , 1999, The Journal of pharmacology and experimental therapeutics.
[51] M. Sekiguchi,et al. Analgesic Effects of Prostaglandin E2 Receptor Subtype EP1 Receptor Antagonist: Experimental Study of Application of Nucleus Pulposus , 2011, Spine.
[52] P. Beaulieu,et al. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain , 2006, Pain.
[53] S. Narumiya,et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor , 1997, Nature.
[54] Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists. , 2011, Bioorganic & medicinal chemistry letters.
[55] K. Omote,et al. Role of Prostaglandin Receptor EP1 in the Spinal Dorsal Horn in Carrageenan-induced Inflammatory Pain , 2002, Anesthesiology.
[56] C. Woolf,et al. Pain: molecular mechanisms. , 2000, The journal of pain : official journal of the American Pain Society.
[57] J. Lopshire,et al. The cAMP Transduction Cascade Mediates the Prostaglandin E2 Enhancement of the Capsaicin-Elicited Current in Rat Sensory Neurons: Whole-Cell and Single-Channel Studies , 1998, The Journal of Neuroscience.
[58] R. Riccio,et al. Anti-inflammatory and analgesic activity of a novel inhibitor of microsomal prostaglandin E synthase-1 expression. , 2009, European journal of pharmacology.
[59] F. Kojima,et al. Prostaglandin E synthase in the pathophysiology of arthritis , 2005, Fundamental & clinical pharmacology.
[60] S. Reddy,et al. Prostaglandin Synthase-1 and Prostaglandin Synthase-2 Are Coupled to Distinct Phospholipases for the Generation of Prostaglandin D2 in Activated Mast Cells* , 1997, The Journal of Biological Chemistry.
[61] S. Narumiya,et al. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. , 2005, The Journal of clinical investigation.
[62] K. Brune,et al. Suppressed Injury-Induced Rise in Spinal Prostaglandin E2 Production and Reduced Early Thermal Hyperalgesia in iNOS-Deficient Mice , 2000, The Journal of Neuroscience.
[63] Kazunari Nakao,et al. Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation. , 2008, European journal of pharmacology.
[64] H. Afif,et al. Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. , 2008, Arthritis and rheumatism.
[65] R. Schuligoi,et al. Role of cyclooxygenase-2 in gastric mucosal defense. , 2001, Life sciences.
[66] James A. Clark,et al. Defective Generation of a Humoral Immune Response Is Associated with a Reduced Incidence and Severity of Collagen-Induced Arthritis in Microsomal Prostaglandin E Synthase-1 Null Mice1 , 2008, Journal of Immunology.
[67] L. Audoly,et al. A novel role of prostaglandin E2 in neuropathic pain , 2011, Glia.
[68] M. Vasko,et al. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons. , 1997, Journal of neurophysiology.
[69] H. Wässle,et al. GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization , 2004, Science.
[70] L. Ballou,et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. , 2000, Arthritis and rheumatism.
[71] D. Willoughby,et al. Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti‐inflammatory therapy , 1995, The Journal of pathology.
[72] David Julius,et al. Cellular and Molecular Mechanisms of Pain , 2009, Cell.
[73] A. Naylor,et al. Discovery of GSK345931A: An EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain. , 2009, Bioorganic & medicinal chemistry letters.
[74] K. Seibert,et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[75] C. Hay,et al. Dexamethasone prevents the induction of COX-2 mRNA and prostaglandins in the lumbar spinal cord following intraplantar FCA in parallel with inhibition of oedema , 1998, Neuropharmacology.
[76] C. Woolf,et al. Direct Activation of Rat Spinal Dorsal Horn Neurons by Prostaglandin E2 , 2001, The Journal of Neuroscience.
[77] S. Narumiya,et al. Evidence for involvement of prostaglandin I2 as a major nociceptive mediator in acetic acid-induced writhing reaction: a study using IP-receptor disrupted mice. , 1999, Advances in experimental medicine and biology.
[78] P. Clark,et al. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a Selective E Prostanoid Receptor 4 Antagonist, Relieves Joint Inflammation and Pain in Rodent Models of Rheumatoid and Osteoarthritis , 2008, Journal of Pharmacology and Experimental Therapeutics.
[79] T. Grosser,et al. Emotion recollected in tranquility: lessons learned from the COX-2 saga. , 2010, Annual review of medicine.
[80] M. Vasko,et al. Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[81] S. Narumiya,et al. The DP receptor, allergic inflammation and asthma. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[82] W. Neupert,et al. Peripheral noxious stimulation releases spinal PGE2 during the first phase in the formalin assay of the rat. , 1997, Life sciences.
[83] C. Woolf,et al. Prostaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity , 2006, Journal of Pharmacology and Experimental Therapeutics.
[84] D. Riendeau,et al. Prostacyclin Antagonism Reduces Pain and Inflammation in Rodent Models of Hyperalgesia and Chronic Arthritis , 2006, Journal of Pharmacology and Experimental Therapeutics.
[85] M. Vasko,et al. The cAMP transduction cascade mediates the PGE2‐induced inhibition of potassium currents in rat sensory neurones , 1999, The Journal of physiology.
[86] J. Eisenach,et al. Cyclooxygenase-1 in the spinal cord plays an important role in postoperative pain , 2003, Pain.
[87] M. Breyer,et al. Physiological regulation of cyclooxygenase-2 in the kidney. , 2001, American journal of physiology. Renal physiology.
[88] Hyung-Suk Kim,et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.
[89] M. Marsala,et al. Effect of spinal kainic acid receptor activation on spinal amino acid and prostaglandin E2 release in rat , 1996, Neuroscience.
[90] L. Audoly,et al. Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages* , 2005, Journal of Biological Chemistry.
[91] K. Brune,et al. Analgesic strategies beyond the inhibition of cyclooxygenases. , 2006, Trends in pharmacological sciences.
[92] Lawrence J. Marnett,et al. Cyclooxygenase-1-dependent Prostaglandin Synthesis Modulates Tumor Necrosis Factor-α Secretion in Lipopolysaccharide-challenged Murine Resident Peritoneal Macrophages* , 2004, Journal of Biological Chemistry.
[93] Ying Yu,et al. Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice , 2012, Science Translational Medicine.
[94] C. Brenneis,et al. Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice , 2007, Journal of cellular and molecular medicine.
[95] J. Levine,et al. Modulation of TTX-R INa by PKC and PKA and Their Role in PGE2-Induced Sensitization of Rat Sensory Neurons In Vitro , 1998, The Journal of Neuroscience.
[96] M. A. Tejada,et al. Tetrodotoxin (TTX) as a Therapeutic Agent for Pain , 2012, Marine drugs.
[97] C. Woolf. What is this thing called pain? , 2010, The Journal of clinical investigation.
[98] Y. Sugimoto,et al. Prostaglandin receptors: advances in the study of EP3 receptor signaling. , 2002, Journal of biochemistry.
[99] C. Woolf,et al. Periganglionic inflammation elicits a distally radiating pain hypersensitivity by promoting COX-2 induction in the dorsal root ganglion , 2009, Pain.
[100] P. Isakson,et al. The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1 , 2001, The Journal of Neuroscience.
[101] H. S. Kim,et al. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. , 2001, The Journal of clinical investigation.
[102] T. Grosser,et al. Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2 , 2002, Science.
[103] Makoto Murakami,et al. Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1* , 2004, Journal of Biological Chemistry.
[104] B. Koller,et al. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. , 2001, The Journal of clinical investigation.
[105] D. Sachs,et al. The role of PKA and PKCε pathways in prostaglandin E2‐mediated hypernociception , 2009, British journal of pharmacology.
[106] G. FitzGerald,et al. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. , 2000, The Journal of clinical investigation.
[107] S. Ferreira. Prostaglandins, aspirin-like drugs and analgesia. , 1972, Nature: New biology.
[108] Garret A FitzGerald,et al. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. , 2005, The Journal of clinical investigation.
[109] E. Mazzon,et al. Cyclooxygenases 1 and 2 Contribute to Peroxynitrite- Mediated Inflammatory Pain Hypersensitivity , 2022 .
[110] J. Vane,et al. Nociception in cyclooxygenase isozyme-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[111] J. Falgueyret,et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor , 1997, British journal of pharmacology.
[112] D. Benhamou,et al. The Effect of a Peripheral Block on Inflammation-Induced Prostaglandin E2 and Cyclooxygenase Expression in Rats , 2009, Anesthesia and analgesia.
[113] Garret A. FitzGerald,et al. Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[114] G. FitzGerald,et al. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis. , 2008, Arthritis and rheumatism.
[115] H. Schaible,et al. Effects of prostaglandin D2 on tetrodotoxin-resistant Na+ currents in DRG neurons of adult rat , 2011, PAIN.
[116] I. Chessell,et al. The Voltage-Gated Sodium Channel Nav1.9 Is an Effector of Peripheral Inflammatory Pain Hypersensitivity , 2006, The Journal of Neuroscience.
[117] W. Feniuk,et al. Characterization of the prostanoid receptor types involved in mediating calcitonin gene‐related peptide release from cultured rat trigeminal neurones , 2001, British journal of pharmacology.
[118] L. Crofford,et al. Potential roles of microsomal prostaglandin E synthase-1 in rheumatoid arthritis. , 2011, Inflammation and regeneration.
[119] H. Schaible,et al. Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation , 2008, Neuroscience.
[120] Yasuyoshi Watanabe,et al. Prostaglandin E2 stimulates glutamate release from synaptosomes of rat spinal cord , 1995, Neuroscience Letters.
[121] H. Schaible,et al. Changes in the Effect of Spinal Prostaglandin E 2 during Inflammation : Prostaglandin E ( EP 1 – EP 4 ) Receptors in Spinal Nociceptive Processing of Input from the Normal or Inflamed Knee Joint , 2004 .
[122] S. Narumiya,et al. Major roles of prostanoid receptors IP and EP(3) in endotoxin-induced enhancement of pain perception. , 2001, Biochemical pharmacology.
[123] C. Woolf,et al. Bradykinin Enhances AMPA and NMDA Receptor Activity in Spinal Cord Dorsal Horn Neurons by Activating Multiple Kinases to Produce Pain Hypersensitivity , 2008, The Journal of Neuroscience.
[124] E. Puré,et al. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis , 2006, Proceedings of the National Academy of Sciences.
[125] H. Schaible,et al. The intraspinal release of prostaglandin E2 in a model of acute arthritis is accompanied by an up-regulation of cyclo-oxygenase-2 in the spinal cord , 1999, Neuroscience.
[126] L. Huang,et al. A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2‐induced potentiation of P2X3 receptor currents in inflamed rats , 2007, The Journal of physiology.
[127] S. Narumiya,et al. Contribution of peripheral versus central EP1 prostaglandin receptors to inflammatory pain , 2011, Neuroscience Letters.
[128] S. Bevan,et al. PGE2 modulates the tetrodotoxin‐resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP‐protein kinase A cascade. , 1996, The Journal of physiology.
[129] G. Nicol,et al. Cyclic AMP mediates the prostaglandin E2-induced potentiation of bradykinin excitation in rat sensory neurons , 1995, Neuroscience.
[130] A. Hashimoto,et al. Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase. , 2003, Arthritis and rheumatism.